ERIK PETERSEN: Open Payments
NPI 1922210251 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,767 in 103 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,767
Food & beverage: $2,767
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $498 |
| ABBVIE INC. | 17 | $393 |
| Alkermes, Inc. | 7 | $295 |
| Otsuka America Pharmaceutical, Inc. | 10 | $273 |
| E.R. Squibb & Sons, L.L.C. | 10 | $254 |
| Neurocrine BioSciences, Inc. | 8 | $232 |
| Teva Pharmaceuticals USA, Inc. | 10 | $185 |
| Biogen, Inc. | 6 | $135 |
| Axsome Therapeutics, Inc. | 5 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
Products named: SPRAVATO, VRAYLAR, COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, AUSTEDO XR, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
